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anhydrase II using 19F pseudocontact shift analysis†
Kaspar Zimmermann, Daniel Joss, Thomas Mu¨ntener, Elisa S. Nogueira,
Marc Scha¨fer, Livia Kno¨rr, Fabien W. Monnard and Daniel Ha¨ussinger *
Unraveling the native structure of protein–ligand complexes in solution enables rational drug design. We
report here the use of 19F pseudocontact shift (PCS) NMR as a method to determine ﬂuorine positions of
high aﬃnity ligands bound within the drug target human carbonic anhydrase II with high accuracy. Three
diﬀerent ligands were localized within the protein by analysis of the obtained PCS from simple one-
dimensional 19F spectra with an accuracy of up to 0.8 A˚. In order to validate the PCS, four to ﬁve
independent magnetic susceptibility tensors induced by lanthanide chelating tags bound site-speciﬁcally
to single cysteine mutants were reﬁned. Least-squares minimization and a Monte–Carlo approach
allowed the assessment of experimental errors on the intersection of the corresponding four to ﬁve PCS
isosurfaces. By deﬁning an angle score that reﬂects the relative isosurface orientation for diﬀerent tensor
combinations, it was established that the ligand can be localized accurately using only three tensors, if
the isosurfaces are close to orthogonal. For two out of three ligands, the determined position closely
matched the X-ray coordinates. Our results for the third ligand suggest, in accordance with previously
reported ab initio calculations, a rotated position for the diﬂuorophenyl substituent, enabling a favorable
interaction with Phe-131. The lanthanide–ﬂuorine distance varied between 22 and 38 A˚ and induced 19F
PCS ranged from 0.078 to 0.409 ppm, averaging to 0.213 ppm. Accordingly, even longer metal–ﬂuorine
distances will lead to meaningful PCS, rendering the investigation of protein–ligand complexes
signiﬁcantly larger than 30 kDa feasible.Introduction
In order to localize and study ligands bound to proteins, sources
of structural restraints are required. In contrast to X-ray crys-
tallography1 and cryo-electron microscopy,2 paramagnetic
nuclear magnetic resonance (NMR) spectroscopy can deliver
valuable structural information in solution.3–21 Among other
eﬀects associated with the introduction of paramagnetic metal
centres complexed in a chelating tag, as e.g. residual dipolar
couplings (RDC)17,22–24 or paramagnetic relaxation enhancement
(PRE),13,25–27 pseudocontact shis (PCS) stand out as an ideal
tool to deliver long range information on the localization and
orientation of ligand molecules within proteins taking into
account the 3D structural restraints that can be obtained using
this method and the favourable distance dependence of r3.28–34
To unlock the opportunities that PCS of protein-bound
ligands oﬀer, the NMR signals of the ligand have to be deter-
mined unambiguously. Proton resonances of the ligand usually
overlap with the protein signals, thus, rendering a successfulasel, St. Johanns-Ring 19, 4056 Basel,
ibas.ch
tion (ESI) available. See DOI:
Chemistry 2019assignment diﬃcult. This holds in particular true for ligands
that bind rmly to the protein, since they exhibit the same
rotational correlation time as the protein and their lines are
therefore broadened to a similar extent. This usually renders
a discrimination between protein and ligand signals diﬃcult.
Whereas isotope ltered NMR experiments suﬀer from a low
signal-to-noise ratio and long measurement times, isotopic
labelling of the ligand carbon- and hetero atoms includes
labour intensive chemical modication of the ligand and the
eﬀort has to be repeated for each ligand under investigation.
However, due to the 100% natural abundance of NMR active
isotopes such as 19F or 31P, no further isotope enrichment is
necessary for the acquisition of NMR spectra of molecules
containing these elements. In particular uorine is of great
interest, since whereas in 1970 only 2% of drugs incorporated
uorine, the percentage of drugs containing at least one uo-
rine atom in 2014 amounted to 25%.35 If protein ligands con-
taining 19F are used, their 19F chemical shi can be obtained
directly from one-dimensional 19F NMR spectra, superseding
isotopic labelling of ligands and solvent signal.
We selected three sulphonamide ligands for human
carbonic anhydrase II (hCA II) in order to test their localization
within the protein using PCS NMR spectroscopy (Fig. 1). The
tested ligands are all derivatives of the well-established class ofChem. Sci.
Fig. 1 Selected ligands for our proof-of-principle study.
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View Article Onlinesulphonamide ligands that bind with their sulphonamide
moiety to the zinc ion in the active site of the protein and exhibit
nanomolar aﬃnities to the human carbonic anhydrase II.36–39
In order to unambiguously localize ligands within a protein
using PCS NMR spectroscopy, four diﬀerent anisotropy tensors
need to be determined from four diﬀerent tagging sites or from
less tagging sites by using diﬀerent lanthanide chelating tags
(Fig. 2). Intersection of the isosurfaces of two anisotropy tensors
lead to a remaining curve (Fig. 2B). Intersection of this curve
with a third isosurface leads to two points as remaining possi-
bilities for the localization of the ligand (Fig. 2C). To determine
the position exclusively in a strict mathematic view, a fourth
isosurface is needed (Fig. 2D). However, in practice only three
tensors suﬃce, since the remaining other possibility for the
position of the ligand can usually be excluded due to chemical
and structural reasons, i.e. the remaining “ghost site” lies in
a very dense region or completely outside of the investigated
protein.
With the information about the anisotropy tensors in hand,
compounds can then be screened and their position localized
by measuring only one-dimensional 19F NMR spectra. We
envisioned to introduce ve serine to cysteine mutations suit-
able to serve as tagging sites into hCA II and express the
diﬀerent mutants in diﬀerent labelling schemes, i.e. uniformly
15N labelled, selectively 15N leucine labelled, as well as oneFig. 2 Tensors required for unambiguous localization of a given atom
by using PCS as sole source of structural restraints (A) isosurface (red)
and hCA II (grey), (B) intersection of two isosurfaces, (C): intersection
of three isosurfaces resulting in two intersection points (one visible,
one on the other side of the protein scaﬀold), (D) intersection of four
isosurfaces resulting in only one intersection point (visible in center
of (D)).
Chem. Sci.mutant 2H 13C 15N. Whereas the 15N labelled sample can be
used to record 1H–15N HSQC spectra for determination of the
pseudocontact shis needed for the determination of the
anisotropy tensors, selectively 15N labelled samples are
a convenient starting point for the evaluation of the anisotropy
tensors caused by lanthanide chelating tags. Leucine stands out
as an ideal amino acid type for selective labelling, since it is the
most abundant amino acid in proteins and the selective label-
ling of recombinant proteins is straightforward and inexpen-
sive. For hCA II, the 26 Leu residues (10%) show a favourable
distribution in the primary sequence, as well as in 1H–15N
spectra. The triple labelled mutant was expressed for backbone
assignment and a diamagnetic lutetium tag was attached to the
protein in order to avoid ambiguities in the assignment caused
by a small number of residues that shi upon tagging. Upon
expression, tagging and determination of the anisotropy
tensors, uorine pseudocontact shis can then be analysed in
order to localize the selected ligands within the protein.
In order to obtain suﬃciently large PCS for the localization of
ligands in a protein with a molecular weight and size in the
range of hCA II (diameter: 40–56 A˚, molecular weight: 30 kDa),39
suﬃciently rigid tags have to be used. Lanthanide chelating tags
based on a sterically overcrowded DOTA-M8 scaﬀold11 as well as
the recently reported M7PyThiazole-DOTA21 provided suitable
tools for our intent.
By application of the envisioned methodology, we demon-
strate that the position of ligands within a protein can be
determined solely by measurement of one-dimensional 19F
NMR experiments and analysis of the obtained 19F PCS over
a distance range of 22–38 A˚. Human carbonic anhydrase II is
expressed in three diﬀerent labelling schemes for ve diﬀerent
single-cysteine constructs and three ligands are tested. During
the drug candidate screening process, the presented method
signicantly reduces NMR measurement times compared to
NOE-based approaches and eliminates the need for isotope
labelled protein as well as chemical modication of the ligand.
Furthermore, we observe diﬀerences in the solution structure of
one ligand (F2-Inh) when compared to the crystal structure and
establish an angle score as a measure of the suitability of
chosen anisotropy tensors.Materials and methods
Extensive protocols of the expression of uniformly 15N labelled
hCA II mutants, selectively 15N leucine labelled hCA II mutants,
uniformly 2H 13C 15N labelled hCA II mutants, tagging reac-
tions, NMR experiments and pseudocontact shi analysis are
available in the ESI.†Sample preparation
To a protein sample, 1.1 eq. of ligand dissolved in deuterated
dimethyl sulphoxide (DMSO-d6) were added and the sample was
stirred well. The excess of ligand was removed by ultraltration
using 4 ml Amicon ultraltration tubes (MW cut-oﬀ 10 kDa).
Triuoroacetate as internal standard for uorine chemical shiThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinecalibration as well as 5% v/v D2O were added and the pH was
adjusted to 6.80.NMR experiments
A 1H–15N-HSQC experiment reported by Grzesiek et al.40 with
a pulse sequence including a water suppression scheme using
selective water ip-back pulses and gradients to suppress radi-
ation damping was used for the determination of the PCS, since
it does not cause the small additional shi due to dipolar
coupling (rdc) introduced in TROSY-1H15N-HSQC spectra. For
backbone assignment of uniformly 2H 13C 15N labelled hCA II
S50C Lu-DOTA-M8 and all spectra recorded for protein char-
acterization, TROSY41 variants of HSQC, HNCO, HNCA, HN(CO)
CA, HN(CA)CO and HNCACB experiments incorporating
a WATERGATE scheme were used.42–44 NMR spectra were
recorded on Bruker Avance III or Avance III HD spectrometers
operating at 600.13 MHz proton frequency, equipped with
5 mm BBFO, 1H/13C/15N TXI or 1H/19F–13C/15N-D QCI-F probe
heads, all tted with z-axis pulsed eld gradients.Results and discussion
In order to ensure a rigid and stable attachment point for the
Ln-DOTA-M8-SSPy and Ln-M7PyThiazole-DOTA complexes
without compromising the global fold of hCA II, ve solvent
exposed serine residues in regions of the protein with rigid
secondary structure were selected and mutated to cysteine
(Fig. 3). The native cysteine residue 206 was replaced by a serine
for all constructs to avoid any interference. Double mutants
containing this modication, e.g. hCA II S50C C206S, are
abbreviated in the following, e.g. as hCA II S50C.
Although an NMR assignment for the wild type protein is
available,45 a backbone assignment of uniformly 2H 13C 15N
labelled hCA II S50C Lu-DOTA-M8 was performed to have an
unambiguous assignment including the shied residues close
to the tagging site. In order to provide a convenient starting
point for the PCS assignment, selectively 15N leucine labelled
hCA II mutants were expressed. Having selectively 15N leucine
labelled protein and an assignment of uniformly labelled hCA II
tagged with Lu-DOTA-M8 for our purpose in hand, more than
eight shied peaks were readily assigned for each mutant from
an overlay of the 1H–15N HSQC spectra of diamagnetic Lu-Fig. 3 X-ray structure of hCA II (3KS3). Red: selected serine to cysteine
mutation sites, yellow: native Cys-206, blue: leucine residues and
orange: zinc ion.
This journal is © The Royal Society of Chemistry 2019DOTA-M8-SSPy and paramagnetic Tm-DOTA-M8-SSPy attached
to selectively 15N leucine labelled hCA II (Fig. 4). Based on the
assigned PCS for the leucine residues, the remaining PCS can be
back-calculated using the initially tted anisotropy tensor.
Although it is possible to start the analysis of the PCS from the
fully labelled protein (in the less crowded regions of the spec-
trum), this method simplies considerably the analysis of the
spectra. The mutant hCA II S173C was excluded from further
analysis due to the appearance of two sets of signals in the
HSQC spectrum of the thulium tagged construct. These two sets
arise most likely from two equally populated positions of the tag
molecule when attached to the protein, since residue 173 is
located on the edge of a beta sheet (Fig. 9 and 10 in ESI†).
Parameters describing the magnetic susceptibility tensor of
the lanthanide metal were then determined from this initial set
of PCS using the program Numbat and the X-ray structure of
hCA II (PDB code: 3KS3).46,47 The initially obtained tensor set
allowed to back-calculate the expected PCS for the remaining
leucine residues. Upon unambiguous assignment of all
remaining shied peaks apart from those leucine residues in
a distance smaller than 10.9 A˚ from the tag, where the signals
were either broadened beyond the limit of detection due to PRE
or shied outside of the spectral window, rened tensor
parameters were then calculated from this larger set of PCS.
Subsequently, a complete assignment and evaluation of the
magnetic susceptibility tensors using all detectable resonances
was performed (Fig. 5). The rened tensors for the uniformly
labelled hCA II coincided within 20% with the initial tensors of
the 15N selectively leucine labelled protein constructs.
Table 1 lists the rened tensor parameters obtained for the
diﬀerent protein mutants and used Monte–Carlo methods. All
metal coordinates were located in a distance range of 6–8 A˚ to
the g-oxygen of the serine residue at the position where theFig. 4 Overlay of the 1H–15N-HSQC spectra (600 MHz, 298 K) of
selectively 15N leucine labeled hCA II S50C Lu-DOTA-M8-SSPy (black)
and hCA II S50C Tm-DOTA-M8-SSPy (red). Assignment and PCS are
indicated.
Chem. Sci.
Table 1 Reﬁned magnetic susceptibility tensor parameters for the diﬀer
Parameter Unit S50C Tm-DOTA S166C Tm-DOTA
No. of PCS — 366 397
Dcax [10
32 m3] 21.6  1.2 38.5  2.0
Dcrh [10
32 m3] 8.5  0.7 8.0  1.0
x [A˚] 27.8  0.3 16.3  0.4
y [A˚] 13.7  0.3 3.6  0.4
z [A˚] 18.1  0.3 11.2  0.4
a [] 104.1  1.6 52.2  1.8
b [] 142.3  1.1 123.6  1.4
g [] 116.2  1.7 140.3  5.6
Q 0.072 0.037
Monte–Carlo structure variation with s ¼ 0.5 A˚
No. of PCS — 366 397
Dcax [10
32 m3] 21.1  0.9 37.4  0.9
Dcrh [10
32 m3] 8.5  0.6 7.8  0.6
x [A˚] 27.5  0.3 16.2  0.2
y [A˚] 13.6  0.2 3.6  0.2
z [A˚] 18.2  0.2 11.0  0.2
a [] 104.0  1.8 52.7  1.2
b [] 141.8  0.8 123.1  0.7
g [] 115.9  1.7 141.1  2.7
Q 0.071 0.035
Monte–Carlo protocol where random subsets consisting of 20% of the av
Fig. 5 Overlay of the 1H–15N HSQC spectra (600 MHz, 298 K) of
uniformly 15N labeled hCA II S50C Lu-DOTA-M8-SSPy (black) and hCA
II S50C Tm-DOTA-M8-SSPy (red). Aliased signals with negative
intensity are shown with dashed contour lines. PCS are indicated with
solid and NH2 groups with dashed lines. Water signal was omitted for
clarity.
Chem. Sci.
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View Article Onlinecorresponding sulphur atom of the protein mutant is expected
and the obtained Q-factors for the ts of 3.5–10.6% were
excellent. For the mutants S50C, S217C and S220C similar
values for Dcax were found, whereas this value was almost twice
as large for the S166Cmutant indicating a lower exibility of the
tag when attached to the protein.48 This was also reected in the
obtained pseudocontact shis, where signicantly larger shis
were found for the S166C mutant. An extensive protocol of the
PCS assignment and tting procedure applied is given in the
ESI.† In order to have a further anisotropy tensor at hand, Lu-
and Tm-M7PyThiazole-DOTA were attached to selectively 15N
leucine labelled hCA II S166C and the anisotropy tensor of the
magnetic susceptibility was determined (Table 1). The addi-
tional lanthanide chelating tag was introduced, since it was
expected to be orthogonal to the already investigated constructs
and we wanted to demonstrate that successful localization of
the ligand is possible with a combination of tensors from
uniformly and selectively leucine labelled constructs.
In order to test the newly developed approach for the local-
ization of ligands within a protein of interest, three sulphona-
mide ligands were added to the protein as a dimethyl
sulphoxide (DMSO) solution in small excess of 1.1 eq. to ensure
saturation of the protein with ligand. Complete loading of the
protein with ligand was then conrmed by 1H–15N HSQC
spectra. Due to the high aﬃnity of phenyl-sulphonamide based
ligands,38,39 the excess ligand could then be removed by ultra-
ltration. Chemical shi changes upon ligand binding were
only observed for the residues in the binding pocket of the
protein, which indicates that the overall structure of the protein
did not change upon binding to the ligand.
19F PCS in the range of 0.078 to 0.409 could be observed
for the ve investigated hCA II constructs (Fig. 6, 6 and 7 inent hCA II constructs
S217C Tm-DOTA S220C Tm-DOTA S166C Tm-Thiazole
364 366 44
25.7  1.0 23.6  0.9 34.7  0.6
13.2  0.6 4.3  0.3 13.3  1.1
24.9  0.2 13.1  0.3 11.8  0.5
17.7  0.3 26.7  0.3 1.7  0.1
19.6  0.2 3.2  0.2 11.0  0.2
143.7  0.8 14.9  1.4 119.4  4.4
70.9  0.5 153.6  0.6 162.1  0.5
125.5  1.0 1.0  2.6 44.8  3.7
0.064 0.106 0.061
s ¼ 0.05 A˚
364 366 44
25.5  1.1 23.0  2.1 34.3  0.8
13.1  0.6 4.4  0.8 12.7  1.6
24.8  0.2 13.0  0.6 12.0  0.7
17.5  0.3 26.4  0.6 1.8  0.2
19.6  0.2 3.2  0.5 10.8  0.4
143.3  0.8 16.2  3.5 121.6  6.8
71.2  0.7 153.7  1.5 161.6  1.1
125.1  1.1 3.9  6.6 45.1  5.2
0.068 0.106 0.059
ailable PCS were used
This journal is © The Royal Society of Chemistry 2019
Fig. 6 One-dimensional 19F NMR spectra (565 MHz, 298 K) of F2-Inh
in the presence of diﬀerent hCA II constructs. Spectra of diamagnetic
hCA II constructs with F2-Inh did not show any diﬀerences, therefore
only one diamagnetic reference spectrum is displayed. 19F chemical
shift was calibrated to an internal signal of triﬂuoroacetate at
79.0 ppm.
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View Article OnlineESI†). Interestingly, the uorine atoms of the ligand in hCA II
S166C-Tm-Thiazole shi in the opposite direction when
compared to the signals for hCA II tagged with Tm-DOTA-M8-
SSPy. This shi behaviour originates in the diﬀerent Euler
angles (a, b, g) observed for the individual tags. The linewidths
of the signals correspond to 20–30 Hz for the ligands FM-519
and FM-520, 40–50 Hz for the signal of the uorine atom of
F2-Inh in meta position and 60–70 Hz for the signal of the
uorine atom of F2-Inh in ortho position. When comparing
these values with linewidths obtained by Eddy et al. for the b2-
AR(TETC265)-carazolol complex in the range of 220–230 Hz (ref.
49) and by considering the thermal displacement parameters in
the PDB 1G54,50 it can be concluded that the aromatic ring of
the ligands used in this study pointing out of the enzyme's
pocket still exhibits residual mobility. The largest PCS using
Tm-DOTA-M8-SSPy was observed for the hCA II S166C mutant,
caused by the lower mobility of the tag with respect to the
protein.48 The observed PCSs of a given value are found on an
isosurface dened as follows:
dPCS ¼ 1
12pr3

Dcax

3cos2 q 1þ 3
2
Dcrh sin
2
q cos 2f

whereas dPCS is an experimentally determined PCS, Dcax and
Dcrh are the axial and rhombic components of the magnetic
susceptibility tensor. The solutions for a given PCS and Dcax
and Dcrh of this equation for the polar coordinates r, q and 4,
deliver the mentioned isosurface. The position and orientation
of this isosurface within a reference coordinate system is
determined by three Euclidean coordinates of the correspond-
ing lanthanidemetal and three Euler angles (a, b, g) given in the
ZYZ0 convention.46
According to these considerations, when four back-
calculated PCSs of diﬀerent tensors are available, the position
of a specic nucleus can be determined by the method of least
squares. A sum of square residuals was dened as follows:This journal is © The Royal Society of Chemistry 2019sðx; y; zÞ ¼
Xn
i¼1

dPCSi

x0i; y
0
i; z
0
i
 dPCSi ðexperimentÞ2
where i is the index of a corresponding tensor and n is the total
number of individual tensors available. dPCSi (experiment) is the
experimental PCS for the analyzed tensors and dPCSi ðx0i; y0i; z0iÞ is
dened as follows:
dPCSi

x0i; y
0
i; z
0
i

¼ 1
12pri3
"
Dcax;i
2

z0i
2  x0i2  y0i2
ri2
þ 3
2
Dcrh;i

x0i
2  y0i2
ri2
#
ðx0i; y0i; z0iÞ are the coordinates x, y, z transformed into the
according tensor frame. This transformation is carried out by
translation of the reference coordinate system to the position of
the corresponding metal center and rotation of the coordinate
system by the three Euler angles (a, b, g) which are given for
each tensor. Dcax,i, Dcrh,i and ri correspond to the axial and
rhombic tensor components and the distance between lantha-
nide metal and the observed position (x, y, z) respectively.
The optimized position of the uorine atoms of the used
ligands was then determined by minimization of the target
function s(x, y, z) dened above using the SciPy library.51 Error
analysis of the determined uorine position was performed
applying a Monte–Carlo protocol where the tensor parameters
were varied for every iteration according to the uncertainties
determined in Numbat. For each uorine position, 10 000
iterations were carried out with a random seed in order to
ensure comparability. The resulting values and uncertainties
were the average and standard deviation of these 10 000
iterations.
Interestingly, upon analysis of the obtained pseudocontact
shis and calculation of the position of the ligand, we unam-
biguously and successfully localized all three inhibitors within
the protein using uorine pseudocontact shi restraints over
a distance range of 22–38 A˚. Since the achieved distances for the
localization of a ligand within a protein using lanthanideFig. 7 Point cloud of the Monte–Carlo ﬂuorine position calculation
for FM-519 3 hCA-II (modiﬁed PDB 1G54,50 procedure in ESI†); light
blue stick: ﬂuorine atom, blue sphere: Zn2+ ion.
Chem. Sci.
Fig. 8 Point cloud of the Monte–Carlo ﬂuorine position calculation
for FM-5203 hCA-II (modiﬁed PDB 1G54,50 procedure in ESI†); light
blue sticks: ﬂuorine atoms, blue sphere: Zn2+ ion.
Chemical Science Edge Article
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View Article Onlinechelating tags are in the range of 9.9–25 A˚ (Xu et al.: 14.8–19.4
A˚,34 Saio et al.: 9.9 A˚,28 Guan et al.: 15–25 A˚ (ref. 29)), this result
constitutes an unprecedented distance range.Table 2 Positional accuracy derived by the intersection of diﬀerent com
with the X-ray structure (procedures in ESI)
Ligand
S50C
Tm-DOTA
S166C
Tm-DOTA
S217C
Tm-DOTA
S220C
Tm-DOTA
S166C-
Tm-Thiazo
FM-520 3 3 3 x 3
3 3 3 x x
3 3 x x 3
3 x 3 x 3
x 3 3 x 3
FM-519 3 3 3 x 3
3 3 3 x x
3 3 x x 3
3 x 3 x 3
x 3 3 x 3
F2-Inh
(ortho-F)
3 3 3 3 3
3 3 3 x x
3 3 x 3 x
3 3 x x 3
3 x 3 3 x
3 x 3 x 3
3 x x 3 3
x 3 3 3 x
x 3 3 x 3
x 3 x 3 3
x x 3 3 3
F2-Inh
(meta-F)
3 3 3 3 3
3 3 3 x x
3 3 x 3 x
3 3 x x 3
3 x 3 3 x
3 x 3 x 3
3 x x 3 3
x 3 3 3 x
x 3 3 x 3
x 3 x 3 3
x x 3 3 3
Chem. Sci.The back-calculated positions for the uorine atoms of FM-
519 and FM-520 show a deviation of 3.3 and 0.8 A˚ when
compared to the closely related X-ray structure of the penta-
uoro derivate (PDB 1G54 (ref. 50)). Both the graphical analysis
using the tensor isosurfaces for a given PCS value as well as the
performed Monte–Carlo simulations yield similar positions for
the uorine atoms (Fig. 7 and 8, Table 2).
The results obtained for FM-519 and FM-520 show that the
method is applicable for the localization of ligands of a protein
with a reasonable precision by only acquiring one-dimensional
19F spectra and analysis of the obtained pseudocontact shis.
Compared to the X-ray structure (PDB 1G52 (ref. 50)), the
determined uorine positions for F2-Inh diﬀered by 1.6 A˚ for the
uorine atom in meta position of the diuorophenyl substituent
and by 2.6 A˚ for the uorine atom in ortho position (Fig. 9).
Interestingly, this result is only obtained when the diuorophenyl
substituent of the ligand is rotated by 157 in a way that it aligns
in a nearly perpendicular fashion with the neighbouring
phenylalanine ring of the residue F131. Supported by MP2binations of isosurfaces, their associated angle score and comparison
le
Positional deviation
from X-ray structure (A˚)
Pos. dev. obtained using
combinations with
angle score < 30 (A˚)
Angle
score ()
0.8 — —
1.8 1.2 14.3
2.1 2.7 29.8
2.8 2.1 19.2
9.3 9.6 40.0
3.3 — —
4.1 1.3 10.3
2.5 2.8 28.5
4.7 1.9 18.1
10.9 11.2 34.0
2.7 — —
4.3 1.3 23.2
3.2 1.2 25.7
1.9 5.3 24.0
4.3 1.0 14.4
5.2 2.0 21.8
13.0 9.2 38.2
4.3 1.1 29.0
8.1 4.8 29.4
9.8 6.6 49.6
11.3 7.6 45.3
1.7 — —
3.9 1.0 14.7
6.7 3.4 28.8
3.3 5.9 24.8
4.0 1.1 14.5
5.3 3.8 30.5
5.2 3.5 30.3
4.6 1.3 29.4
9.1 6.2 32.2
13.3 10.2 42.4
16.3 12.9 47.4
This journal is © The Royal Society of Chemistry 2019
Fig. 9 Point clouds of the Monte–Carlo ﬂuorine position calculation
for F2-Inh 3 hCA- II. Red points are obtained from the PCS of the
ﬂuorine in ortho position and the blue points from the ﬂuorine inmeta
position respectively (diﬂuorophenyl substituent of the ligand rotated
by 157 (modiﬁed PDB 1G52 (ref. 50)); light blue sticks: ﬂuorine atoms,
blue sphere: Zn2+ ion.
Fig. 10 Intersection points of diﬀerent isosurfaces for FM-520 3
hCA-II (cyan: center of gravity of the CF3 ﬂuorine atoms of FM-520
(modiﬁed PDB 1G54,50 procedure in ESI†), gold: position obtained by
least square minimization using all four tensors; orange and red:
positions obtained by intersecting three isosurfaces in all possible
combinations; orange: angle score below 30, red: angle score above
30); light blue sticks: ﬂuorine atoms.
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View Article Onlinecalculations that investigated the inuence of the uorine
substitution pattern of the diuorophenyl substituent on the
interactions with a benzene ring and were published in a previous
study52 (ref. 52, page 2, motif 1b), we propose that in the solution
state structure of F2-Inh the diuorophenyl substituent adopts
the described position (Fig. 9).
Notably, the intramolecular uorine–uorine distance in F2-
Inh was determined as 3.5 A˚, reproducing the distance obtained
in the X-ray structure (2.8 A˚) with an accuracy of 0.7 A˚. This result
corroborates the high accuracy of the method presented in this
work. Upon primary localization of the uorine-containing ligand
within the protein, further optimization of the position could be
performed using protein–ligand docking soware.
In order to investigate the precision and accuracy of the
graphical analysis of the presented method by using three iso-
surfaces, we iterated through all possible combinations of three
isosurfaces for the measured PCS for FM-520. Using a Python
script, the normal vectors at the intersection point were deter-
mined and their intersection angle was extracted.
The closer the obtained angle matches 90, the more
precisely the position of a uorine atom is dened at the
intersection point. We then added up the obtained normalized
diﬀerences to 90 of the diﬀerent pairs of the normal vectors to
get an angle score. An angle score of 0 means perfectly
orthogonal intersections, while 90 results from parallel iso-
surfaces. The positions determined from three isosurfaces with
an angle score below 30 closely matches the determined
position using Monte–Carlo protocols with 4 tensors (orange
spheres in Fig. 10). For three isosurfaces with an unfavourable
angle score of 40 we found a signicant deviation of 10 A˚ from
the above position (red sphere in Fig. 10). However, the ach-
ieved accuracy would still be high enough to discriminate e.g.
two distant binding sites in a protein.
In summary, the results for FM-519, FM-520 and F2-Inh
show that it is possible to unambiguously localize a ligand
approaching an accuracy of 0.8 A˚ based solely on the uorine
pseudocontact shi caused by lanthanide chelating tags byThis journal is © The Royal Society of Chemistry 2019measuring 4–5 data points per ligand obtained from one-
dimensional 19F spectra, which provide one unique solution
for the position the ligand. Interestingly, for F2-Inh the results
obtained with our method suggest diﬀerences of the solution
state and crystal state structure. The graphical analysis using
only three tensors shows a precision that is suﬃcient to
discriminate two binding sites within a protein. When only
combinations are taken into account showing an angle score
below 30, the obtained accuracy allows a clear localization of
the uorine atom and the position matches the one determined
in Monte–Carlo protocols using 4 tensors. By omitting the need
for solvent suppression, chemical modication of the ligand
and extensive measurement times during the screening
process, the method constitutes a fast, reliable and convenient
approach to screen a high number of uorine-containing
ligands for a specic protein of interest.
Conclusions
To conclude, it was demonstrated for the rst time that the
position of ligands within a protein can be determined solely by
measurement of one-dimensional 19F NMR experiments and
analysis of the obtained 19F PCS over a distance range of 22–38 A˚
in a protein of a molecular weight of 30 kDa. Human carbonic
anhydrase II was expressed in diﬀerent labelling schemes for ve
diﬀerent single-cysteine constructs and three ligands were tested.
During the drug candidate screening process, the presented
method drastically reduces NMR measurement times compared
to NOE experiments and eliminates the need for isotope labelled
protein as well as labour intensive chemical modication of the
ligand. Due to the large PCS observed over a distance range of 22–
38 A˚, the method could be extended to proteins signicantly
larger than 30 kDa, allows for the investigation of deeply buried
ligand binding sites, avoids interference of the tag with the ligandChem. Sci.
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View Article Onlineinteraction site and renders monitoring of ternary or quaternary
protein ligand complexes feasible.Conﬂicts of interest
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